Type 2 diabetes is the most common type of diabetes. And, while a healthy diet can help in managing the disease, there is also a beverage that is suited for diabetics.
Blood glucose or blood sugar coming from the food you eat is your body's main source of energy. In response to the presence of glucose, your pancreas makes the hormone insulin, which helps the glucose get into your cells to be used as energy.
Diabetes happens when your body either cannot produce enough insulin, or it cannot use insulin properly.
In type 2 diabetes, your pancreas is not able to make enough insulin that is required because your body has become resistant to its effect. Thus, the glucose builds up in your blood.
If you have type 2 diabetes, it is important for you to be careful about what you eat aside from taking medication.
You have to make sure that your blood glucose will not spike, or it will stay high for a long period of time to avoid more complications in your health.
Not only should you be careful about what you eat, but you should also be careful about what you drink.
According to the Daily Express, one of the best drinks that a diabetic patient can take is water.
Drinking lots of water all throughout the day will keep your blood hydrated when the body attempts to get rid of the excess glucose through the urine.
If you are not drinking enough water, your body will not be able to remove excess glucose through your urine, and this will lead to further dehydration.
Water does not contain any calories, so it is safe for diabetic patients to drink plenty of it all day.
According to a study, water will not increase the level of glucose in the blood. The study further found out that when a person's glucose level is too high, the excess glucose will be flushed out of the bloodstream by drinking more water.
Thus, that is why health experts recommend water as the best beverage for type 2 diabetic patients.
Image credit courtesy of Enid Martindale/Flickr


Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 



